Please assess the completion status of the following clinical trial:

Trial Title: The MiDAS ENCORE Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. 65 years or older and a Medicare beneficiary.~2. Patients experiencing neurogenic claudication symptoms for at least 3 months duration which has failed to respond or poorly responded to physical therapy, home exercise programs, and oral analgesics.~3. LSS with neurogenic claudication diagnosed via:~   1. Symptomatic diagnosis and~  2. Radiologic evidence of LSS with unilateral or bilateral ligamentum flavum \>2.5mm confirmed by pre-op MRI or CT performed within 12 months of baseline visit.~4. Patients with comorbid conditions commonly associated with spinal stenosis, such as osteophytes, facet hypertrophy, minor spondylolisthesis, foraminal stenosis, and/or disk protrusion may be included unless the treating physician has determined that the condition is too advanced.~5. Available to complete 6 month and one year follow-up visits.~Exclusion Criteria:~1. ODI Score \< 31 (0-100 ODI Scale).~2. NPRS Score \< 5 (0-10 NPRS Scale).~3. Prior surgery at any treatment level.~4. History of recent spinal fractures with current related pain symptoms.~5. Patients with Grade III or higher spondylolisthesis.~6. Motor deficit or disabling back and/or leg pain from causes other than LSS neurogenic claudication (e.g., acute compression fracture, metabolic neuropathy, or vascular claudication symptoms, etc.).~7. Unable to walk ≥ 10 feet unaided before being limited by pain. In this context, 'unaided' means without the use of a cane, walker, railing, wall, another person or any other means of walking assistance.~8. Patients previously randomized and/or treated in this clinical study.~9. Patients that have previously received the MILD procedure.~10. ESI during eight weeks prior to study enrollment.~11. Epidural lipomatosis (if it is deemed to be a significant contributor of canal narrowing by the physician).~12. On (or pending) Workman's Compensation or known to be considering litigation associated with back pain.

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MILD (Type: ACTIVE_COMPARATOR): The MILD procedure is an image-guided minimally-invasive lumbar decompression
- Epidural Steroid Injection (ESI) (Type: ACTIVE_COMPARATOR): An epidural steroid injection (ESI) is a combination of a corticosteroid with a local anesthetic pain relief medicine.

Based on this trial design, predict the completion outcome and termination type (if applicable).